DES (Diethylstilbestrol)
[back] Drugs in pregnancy  Covert Drug Agendas  Birth defects

[A synthetic oestrogen (female sex hormone) that was prescribed during the 1950s, 1960s and early 1970s to pregnant women mainly to prevent miscarriage but also for complications in pregnancy such as diabetes and high blood pressure.  This has left two key DES-exposed groups: DES mothers and their daughters and sons. DES has been found to cause birth defects in the reproductive tracts of some DES children, and it also causes a rare form of cancer of the vagina or cervix in some DES daughters.]

See: Covert Drug Agendas

The era immediately following WWII saw a veritable explosion of new drugs and bio-active chemicals.  Many resulting from war related R&D efforts instigated in the late 1930s and early 1940s.  Insecticides such as DDT, and antibiotics such as penicillin revolutionized human civilization, resulting in changed expectations that are still influencing society today.  In this environment of sweeping societal transformations, it was a relatively simple matter for the NSA to covertly promote new and novel uses for drugs and other chemicals that would result in creation of children with the required cluster of teratogen induced birth defects.  One of the most widely prescribed and thoroughly documented (teratogenic) synthetic hormone analogs of that period was DES (diethylstilbestrol).  First synthesized in 1938 at the university of Oxford, and approved by the FDA for prevention of miscarriages in 1947, DES was manufactured and sold by pharmaceutical giant Eli Lilly until 1997.  Even though the teratogenic properties of DES were (publicly) documented in 1971.  It is estimated that between 1941 to 1971, five to ten million pregnant (American) women had taken DES, thereby exposing their unborn children to this teratogenic drug.  All of this, in spite of the fact that a 1953 (double blind) study found pregnant women who were given DES had just as many miscarriages and premature deliveries as the control group.  Are we to believe the FDA allowed the continued use of an ineffective drug (on pregnant woman) for eighteen years?  Or was there a hidden agenda behind their apparent lapse of oversight?
    If we assume that only one in every hundred of these (DES exposed) children developed enhanced psychic abilities, and of those, only one in ten were of sufficient strength to be useful in psychic warfare, then this single teratogenic drug added five to ten thousand potential soldiers to the NSA psychic slave army.  All without any public awareness of the real motivation behind introduction and aggressive DES promotion.  Truly, subterfuge and collateral damage on a massive scale.
    DES is typical of first generation teratogenic inducers of psychic abilities.  Besides wide spread (covert) promotion of drugs like DES, the NSA exploited other avenues in their quest to create children with enhanced psychic capabilities.  For instance, medical staff at facilities for unwed teen mothers were infiltrated (subverted), thereby enabling the covert use of experimental teratogenic drugs on naive underage girls.  It is a safe assumption that in the intervening decades since WWII, NSA funded pharmaceutical research has developed a number of more potent (and narrowly targeted) teratogenic drugs for use on an unsuspecting population.
    Along with synthetic hormone analogs (such as DES), certain organic chemicals used in the production of plastics, also exhibit a similar ability to disrupt normal gender specific fetal development.  A good example is BPA (bisphenol A).  Known to mimic natural hormones since the 1930s, it remains in wide spread use today (including the manufacture of baby bottles and other food containers).  National Security Agency (NSA) - Part 3. Collateral damage by Steven J. Smith